Physician profile
Timur Roytman
NPI 1952458176
$21,593.81
in general payments reported to CMS, 2019-2025
20 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,831 · 2020: $504 · 2021: $761 · 2022: $2,634 · 2023: $570 · 2024: $648 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,706 · Consulting Fee: $4,125 · Food and Beverage: $2,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,706.25 |
| Consulting Fee | $4,125.00 |
| Food and Beverage | $2,032.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $10,793.87 | 2021-2025 | Urolift, Barrigel |
| Intuitive Surgical, INC. | $4,664.63 | 2019-2021 | |
| Telix Pharmaceuticals | $2,250.00 | 2022 | |
| Neotract INC. | $1,479.09 | 2019-2020 | |
| Astellas Pharma US INC | $732.24 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $503.43 | 2022-2025 | Erleada, Akeega, Rybrevant |
| Pfizer INC. | $399.44 | 2021-2025 | |
| Boston Scientific Corporation | $235.19 | 2019-2024 | Lithoclast |
| Myovant Sciences INC. | $123.56 | 2021-2022 | |
| Karl Storz Endoscopy-America | $106.54 | 2021 | |
| Sumitomo Pharma America, INC. | $61.78 | 2023-2025 | Orgovyx |
| Ethicon US, LLC | $41.98 | 2022 | |
| Smith+Nephew, INC. | $40.19 | 2020-2021 | |
| Amgen INC. | $36.63 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $35.71 | 2023 | Bard Urinary Drainage Bag |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $27.38 | 2024 | Axonics |
| Urogen Pharma, INC. | $22.21 | 2025 | |
| Laborie Medical Technologies Corp. | $15.01 | 2020 | |
| Abbvie INC. | $13.33 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timur Roytman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.